Although GLP-1s alone cannot be the answer to Indias burgeoning epidemics of diabetes and obesity, they offer hope for many who are struggling with these conditions, especially since drug prices are expected to fall further by March or April
Protein and resistance training are not optional extras on this combo
In February 2022, Viatris entered into an agreement with Biocon Biologics, contributing its biosimilars portfolio and related commercial and operational capabilities in exchange for up to $3.335 billion, including a stake of at least 12.9 percent in Biocon Biologics
Experimental studies in animal models and in vitro systems suggest that DSIP can influence the release of hormones such as growth hormone, luteinizing hormone, and adrenocorticotropic hormone through both hypothalamic and pituitary-level mechanisms [8]
People planning to come off anti-obesity medication should not abruptly stop it but rather de-escalate the dose to see if dose reduction is a viable option to maintain some weight loss, said Dr